Overview
Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health.
Dr. Jabs is rated as a Distinguished provider by MediFind in the treatment of Scleritis. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.
His clinical research consists of co-authoring 140 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Scleritis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, Baltimore, MD 21287
Additional Areas of Focus
Dr. Jabs has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
The Johns Hopkins Hospital
Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as a Distinguished provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.
Medical Faculty Associates, Inc
Hatice Sen is an Ophthalmologist in Washington, Washington, D.c.. Dr. Sen is rated as an Elite provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, Vitrectomy, and Cataract Removal.
The Johns Hopkins Hospital
Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is rated as a Distinguished provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- UveitisDr. Jabs isElite. Learn about Uveitis.
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Jabs isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- CataractDr. Jabs isDistinguished. Learn about Cataract.
- CMV RetinitisDr. Jabs isDistinguished. Learn about CMV Retinitis.
- EpiscleritisDr. Jabs isDistinguished. Learn about Episcleritis.
- Punctate Inner ChoroidopathyDr. Jabs isDistinguished. Learn about Punctate Inner Choroidopathy.
- ScleritisDr. Jabs isDistinguished. Learn about Scleritis.
- Advanced
- Birdshot ChorioretinopathyDr. Jabs isAdvanced. Learn about Birdshot Chorioretinopathy.
- Cataract RemovalDr. Jabs isAdvanced. Learn about Cataract Removal.
- Late-Onset Retinal Degeneration
- NeuroretinitisDr. Jabs isAdvanced. Learn about Neuroretinitis.
- Tuberculous UveitisDr. Jabs isAdvanced. Learn about Tuberculous Uveitis.
- Vogt-Koyanagi-Harada DiseaseDr. Jabs isAdvanced. Learn about Vogt-Koyanagi-Harada Disease.
- Experienced
- Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
- Cicatricial PemphigoidDr. Jabs isExperienced. Learn about Cicatricial Pemphigoid.
- EndophthalmitisDr. Jabs isExperienced. Learn about Endophthalmitis.
- GlaucomaDr. Jabs isExperienced. Learn about Glaucoma.
- Interstitial KeratitisDr. Jabs isExperienced. Learn about Interstitial Keratitis.
- Ocular Hypertension (OHT)Dr. Jabs isExperienced. Learn about Ocular Hypertension (OHT).